| Metric | შპს ირისე | შპს Linema Pharm |
|---|---|---|
| Growth | ||
| Revenue | ₾3.6m₾4.2m | ₾3.9m₾1.6m |
| Revenue growth | -16.1% | 139.8% |
| Profitability | ||
| EBITDA | ₾545k₾934k | ₾1.3m₾465k |
| EBITDA margin | 15.3%22.0% | 32.2%28.7% |
| Net profit | ₾378k₾747k | ₾1.2m-₾90k |
| Net margin | 10.6%17.6% | 31.0%-5.5% |
| Balance sheet | ||
| Total assets | ₾2.5m₾2.6m | ₾7.5m₾6.2m |
| Total equity | ₾2.1m₾2.3m | ₾6.4m₾5.4m |
| ROE | 18.2%32.9% | 18.9%-1.6% |